Inhibitors of monoamine oxidase B: pharmacology and clinical use in neurodegenerative disorders
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Basel ; Berlin <<[u.a.]>>
Birkhäuser
1993
|
| Schriftenreihe: | Milestones in drug therapy
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XVIII, 360 S. Ill., graph. Darst. |
| ISBN: | 3764327820 0817627820 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV026115057 | ||
| 003 | DE-604 | ||
| 005 | 20241127 | ||
| 007 | t| | ||
| 008 | 110326s1993 xx ad|| |||| 00||| eng d | ||
| 020 | |a 3764327820 |9 3-7643-2782-0 | ||
| 020 | |a 0817627820 |9 0-8176-2782-0 | ||
| 035 | |a (OCoLC)611537865 | ||
| 035 | |a (DE-599)BVBBV026115057 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-188 | ||
| 245 | 1 | 0 | |a Inhibitors of monoamine oxidase B |b pharmacology and clinical use in neurodegenerative disorders |c ed. by I. Szelenyi |
| 264 | 1 | |a Basel ; Berlin <<[u.a.]>> |b Birkhäuser |c 1993 | |
| 300 | |a XVIII, 360 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Milestones in drug therapy | |
| 650 | 0 | 7 | |a MAO-Hemmer B |0 (DE-588)4197744-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Selegilin |0 (DE-588)4196756-2 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a MAO-Hemmer B |0 (DE-588)4197744-0 |D s |
| 689 | 0 | 1 | |a Selegilin |0 (DE-588)4196756-2 |D s |
| 689 | 0 | |5 DE-188 | |
| 700 | 1 | |a Szelényi, Iván |d 1938- |0 (DE-588)129480045 |4 edt | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=021706559&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-021706559 | |
Datensatz im Suchindex
| _version_ | 1816873229458866176 |
|---|---|
| adam_text |
IMAGE 1
INHIBITORS OF
MONOAMINE OXIDASE B PHARMACOLOGY AND CLINICAL USE IN NEURODEGENERATIVE
DISORDERS
EDITED BY I. SZELENYI
BIRKHAUSER VERLAG BASEL * BOSTON * BERLIN
IMAGE 2
CONTENTS
PREFACE IX
LIST OF CONTRIBUTORS XI
LIST OF ABBREVIATIONS XIII
INTRODUCTION XV
PARKINSON'S DISEASE: A BRIEF INTRODUCTION
1. ANATOMY OF THE HUMAN BASAL GANGLIA H. BRAAK AND E. BRAAK 3
2. THE PATHOPHYSIOLOGICAL BASIS OF PARKINSON'S DISEASE M. GERLACH AND P.
RIEDERER 25
3. PARKINSON'S DISEASE AND ITS EXISTING THERAPY P.-A. FISCHER 51
CHEMISTRY AND PHARMACOLOGY OF MONOAMINE OXIDASE B INHIBITORS
4. MEDICINAL CHEMISTRY OF PRESENT AND FUTURE MAO-B INHIBITORS J. GADL
AND I. HERMECZ 75
5. /-DEPRENYL: A UNIQUE MAO-B INHIBITOR E. E. POLYMEROPOULOS 109
6. PHARMACOLOGY OF MONOAMINE OXIDASE TYPE B INHIBITORS K. MAGYAR \. 125
7. THE PHARMACOLOGICAL BASIS OF THE THERAPEUTIC EFFECT OF ( - )-DEPRENYL
IN AGE-RELATED NEUROLOGICAL DISEASES /. KNOLL 145
8. NEUROTOXINS AND MONOAMINE OXIDASE B INHIBITORS: POSSIBLE MECHANISMS
FOR THE NEUROPROTECTIVE EFFECT OF ( - )-DEPRENYL V. GLOVER AND M.
SANDIER 169
9. THE MODE OF ACTION OF MAO-B INHIBITORS M. GERLACH, P. RIEDERER AND M.
B. H. YOUDIM 183
10. PHARMACOKINETICS AND CLINICAL PHARMACOLOGY OF SELEGILINE E. H.
HEINONEN, M. I. ANTTILA AND R. A. S. LAMMINTAUSTA. . 201 11.
PRECLINICAL EVALUATION OF /-DEPRENYL: LACK OF AMPHETAMINE-LIKE ABUSE
POTENTIAL
S. YASAR, G. WINGER, B. NICKEL, G. SCHULZE AND S. R. GOLDBERG 215
IMAGE 3
V L LL
CLINICAL EXPERIENCE WITH MONOAMINE OXIDASE B INHIBITORS
12. THE HISTORY OF /-DEPRENYL M. J. PARNHAM 237
13. MAO-B INHIBITORS IN NEUROLOGICAL DISORDERS WITH SPECIAL REFERENCE TO
SELEGILINE K. WESSEL :'. 253
14. (-)-DEPRENYL COMBINED WITH L-DOPA IN THE TREATMENT OF PARKINSON'S
DISEASE T. S. ELIZAN 277
15. NEUROPROTECTIVE EFFECTS OF MAO-B INHIBITION: CLINICAL STUDIES IN
PARKINSON'S DISEASE P. A. LEWITT 289
16. ALZHEIMER'S DISEASE AND /-DEPRENYL: RATIONALES AND FINDINGS P. N.
TARIOT, L. S. SCHNEIDER, S. V. PATEL AND B. GOLDSTEIN . . 301
17. DO MAO-B INHIBITORS HAVE ANY ROLE IN THE TREATMENT OF. ; DEPRESSION?
G. LAUX 319
18. THE THERAPEUTIC PLACE AND VALUE OF PRESENT AND FUTURE MAO-B
INHIBITORS - /-DEPRENYL AS THE GOLD STANDARD P. RIEDERER AND M. B. H.
YOUDIM 327
APPENDIX I
CHEMICAL STRUCTURES AND PHARMACOLOGICAL FEATURES OF MAO-B INHIBITORS W.
PAUL AND I. SZELENYI 339
APPENDIX II
EXPLANATION OF THE NOMENCLATURE FOR OPTICAL ISOMERS E. E. POLYMEROPOULOS
359
SUBJECT INDEX 361 |
| any_adam_object | 1 |
| author2 | Szelényi, Iván 1938- |
| author2_role | edt |
| author2_variant | i s is |
| author_GND | (DE-588)129480045 |
| author_facet | Szelényi, Iván 1938- |
| building | Verbundindex |
| bvnumber | BV026115057 |
| ctrlnum | (OCoLC)611537865 (DE-599)BVBBV026115057 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV026115057</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20241127</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">110326s1993 xx ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3764327820</subfield><subfield code="9">3-7643-2782-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0817627820</subfield><subfield code="9">0-8176-2782-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)611537865</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV026115057</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-188</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Inhibitors of monoamine oxidase B</subfield><subfield code="b">pharmacology and clinical use in neurodegenerative disorders</subfield><subfield code="c">ed. by I. Szelenyi</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel ; Berlin <<[u.a.]>></subfield><subfield code="b">Birkhäuser</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVIII, 360 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Milestones in drug therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">MAO-Hemmer B</subfield><subfield code="0">(DE-588)4197744-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Selegilin</subfield><subfield code="0">(DE-588)4196756-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">MAO-Hemmer B</subfield><subfield code="0">(DE-588)4197744-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Selegilin</subfield><subfield code="0">(DE-588)4196756-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Szelényi, Iván</subfield><subfield code="d">1938-</subfield><subfield code="0">(DE-588)129480045</subfield><subfield code="4">edt</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=021706559&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-021706559</subfield></datafield></record></collection> |
| id | DE-604.BV026115057 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T11:02:15Z |
| institution | BVB |
| isbn | 3764327820 0817627820 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-021706559 |
| oclc_num | 611537865 |
| open_access_boolean | |
| owner | DE-188 |
| owner_facet | DE-188 |
| physical | XVIII, 360 S. Ill., graph. Darst. |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Birkhäuser |
| record_format | marc |
| series2 | Milestones in drug therapy |
| spelling | Inhibitors of monoamine oxidase B pharmacology and clinical use in neurodegenerative disorders ed. by I. Szelenyi Basel ; Berlin <<[u.a.]>> Birkhäuser 1993 XVIII, 360 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Milestones in drug therapy MAO-Hemmer B (DE-588)4197744-0 gnd rswk-swf Selegilin (DE-588)4196756-2 gnd rswk-swf MAO-Hemmer B (DE-588)4197744-0 s Selegilin (DE-588)4196756-2 s DE-188 Szelényi, Iván 1938- (DE-588)129480045 edt GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=021706559&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Inhibitors of monoamine oxidase B pharmacology and clinical use in neurodegenerative disorders MAO-Hemmer B (DE-588)4197744-0 gnd Selegilin (DE-588)4196756-2 gnd |
| subject_GND | (DE-588)4197744-0 (DE-588)4196756-2 |
| title | Inhibitors of monoamine oxidase B pharmacology and clinical use in neurodegenerative disorders |
| title_auth | Inhibitors of monoamine oxidase B pharmacology and clinical use in neurodegenerative disorders |
| title_exact_search | Inhibitors of monoamine oxidase B pharmacology and clinical use in neurodegenerative disorders |
| title_full | Inhibitors of monoamine oxidase B pharmacology and clinical use in neurodegenerative disorders ed. by I. Szelenyi |
| title_fullStr | Inhibitors of monoamine oxidase B pharmacology and clinical use in neurodegenerative disorders ed. by I. Szelenyi |
| title_full_unstemmed | Inhibitors of monoamine oxidase B pharmacology and clinical use in neurodegenerative disorders ed. by I. Szelenyi |
| title_short | Inhibitors of monoamine oxidase B |
| title_sort | inhibitors of monoamine oxidase b pharmacology and clinical use in neurodegenerative disorders |
| title_sub | pharmacology and clinical use in neurodegenerative disorders |
| topic | MAO-Hemmer B (DE-588)4197744-0 gnd Selegilin (DE-588)4196756-2 gnd |
| topic_facet | MAO-Hemmer B Selegilin |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=021706559&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT szelenyiivan inhibitorsofmonoamineoxidasebpharmacologyandclinicaluseinneurodegenerativedisorders |